What people use when they have cancer and want to get well with alternative treatment

NCV (Newcastle virus disease)

Cancer treatment using viruses has been discussed in the clinical literature for years in anecdotal case reports and uncontrolled clinical trials. The earliest references describe patient treated with live attenuated viral vaccines who experienced tumor regression. Several authors have since described regression of tumors in patients during measles and mumps infections, including one study of 90 patients intentionally infected with live mumps virus.

Since 1970 Dr. Laszlo K. Csatary, a Hungarian – American scientist discovered that a poultry farmer with metastasic stomach cancer underwent remission coinciding with an epidemic of Newcastle disease among his chickens. Based in this observation, a small number of terminal cancer patients who had exhausted conventional treatments were treated with an attenuated (weakened) vaccine strain of Newcastle disease virus. The virus therapy produce a favorable results. Actually Dr. Csatary works as a scientist in United Cancer Research Institute in Ft. Lauderdale, Florida and in his native Hungary where he continues his research with NCV (Newcastle virus disease).

Surgical resection offers the chance of cure for some patients with solitary solid mass, and in the expectancy of micro-metastasis spreading; most of the Oncologists in a great number of times recommend Chemotherapy or Radiotherapy. An alternative approach is immunotherapy in order to control the microscopic tumor foci.

Recent data from these ongoing clinical studies were summarized in 1993 in the Journal “Cancer Detection and Prevention” In this phase II multicenter clinical trial, Dr. Csatary and colleagues reported that Newcastle virus either slowed or halted tumor progression in a majority of patients with cancer. Even in cases where tumor progression was not halted, pain lessened, the quality of life improved.

By 1996 several dozens of papers have shown the affectivity of the NCV (Newcastle virus disease) in the medical literature that had documented its anticancer activity, the Journal of the National Cancer Institute (NCI) indicates ” We are entering a new age of viral therapeutics for human cancer”.

NCV (Newcastle virus disease)is an Oncolytic agent with ability to induce tumor lysis through different mechanisms:

Can infect and directly lyse (destroyed) a variety of human tumor cells. NCV can induce Tumor Necrosis factor (Alpha) (TNF) production in human mononuclear cells ( an immune factor that attacks and destroys cancer cells). Furthermore infection of the tumor cells by NCV appears to enhance their sensitivity to the cytolytic effects of TNF. There are other properties of the NCV responsible for specific tumor cell killing that are unexplored.

http://www.sdiegoclinic.com